Formoterol delivered via a dry powder inhaler (Aerolizer^*): Results from long-term clinical trials in childrenPEARLMAN, David S; KOTTAKIS, John; TILL, Denise et al.Current medical research and opinion. 2002, Vol 18, Num 8, pp 445-455, issn 0300-7995, 11 p.Article

Trivalent and quadrivalent MF59^®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding studyDELLA CIOPPA, Giovanni; VESIKARI, Timo; SOKAL, Etienne et al.Vaccine. 2011, Vol 29, Num 47, pp 8696-8704, issn 0264-410X, 9 p.Article

Formoterol provides long-lasting protection against exercise-induced bronchospasmBRONSKY, Edwin A; YEGEN, Ümit; CHING MING YEH et al.Annals of allergy, asthma, & immunology. 2002, Vol 89, Num 4, pp 407-412, issn 1081-1206Article

MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety databasePELLEGRINI, Michele; NICOLAY, Uwe; LINDERT, Kelly et al.Vaccine. 2009, Vol 27, Num 49, pp 6959-6965, issn 0264-410X, 7 p.Article

A randomized, double-blind, single-dose, crossover clinical trial of the onset and duration of protection from exercise-induced bronchoconstriction by formoterol and albuterolSHAPIRO, Gail S; YEGEN, Ümit; JIM XIANG et al.Clinical therapeutics. 2002, Vol 24, Num 12, pp 2077-2087, issn 0149-2918, 11 p.Article

Effects of budesonide and formoterol on NF-κB, adhesion molecules, and cytokines in asthmaWILSON, Susan J; WALLIN, Annika; DELLA-CIOPPA, Giovanni et al.American journal of respiratory and critical care medicine. 2001, Vol 164, Num 6, pp 1047-1052, issn 1073-449XArticle

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaBUSSE, William; CORREN, Jonathan; LANIER, Bobby Quentin et al.Journal of allergy and clinical immunology. 2001, Vol 108, Num 2, pp 184-190, issn 0091-6749Article

A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhalerBENSCH, George; LAPIDUS, Robert J; LEVINE, Bernard E et al.Annals of allergy, asthma, & immunology. 2001, Vol 86, Num 1, pp 19-27, issn 1081-1206Conference Paper

Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysisBLACK, Steven; DELLA CIOPPA, Giovanni; MALFROOT, Anne et al.Vaccine. 2010, Vol 28, Num 45, pp 7331-7336, issn 0264-410X, 6 p.Article

Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern ItalyVILLA, Marco; BLACK, Steven; MALCHIODI, Giancarlo et al.American journal of epidemiology. 2013, Vol 178, Num 7, pp 1139-1145, issn 0002-9262, 7 p.Article

Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young childrenNOLAN, Terry; BRAVO, Lulu; FORLEO, Eduardo et al.Vaccine. 2014, Vol 32, Num 46, pp 6146-6156, issn 0264-410X, 11 p.Article

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary diseaseDAHL, Ronald; GREEFHORST, Louis A. P. M; NOWAK, Dariusz et al.American journal of respiratory and critical care medicine. 2001, Vol 164, Num 5, pp 778-784, issn 1073-449XArticle

Formoterol delivered via a new multi-dose dry powder inhaler (CFrtihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer®) in children with persistent asthmaCHUCHALIN, Alexander G; MANJRA, Ahmed I; ROZINOVA, Nadezhda N et al.Journal of aerosol medicine. 2005, Vol 18, Num 1, pp 63-73, issn 0894-2684, 11 p.Article

One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthmaBENSCH, George; BERGER, William E; BLOKHIN, Boris M et al.Annals of allergy, asthma, & immunology. 2002, Vol 89, Num 2, pp 180-190, issn 1081-1206Article

Effect of Omalizumab on symptoms of seasonal allergic rhinitis: A randomized controlled trialCASALE, Thomas B; CONDEMI, John; FIEK, Robert et al.JAMA, the journal of the American Medical Association. 2001, Vol 286, Num 23, pp 2956-2967, issn 0098-7484Article